Advancing new drug therapies for unmet medical needs

Advancing new drug therapies for unmet medical needs 2017-08-21T11:43:59+00:00

Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)

Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs

Recent news and media

ASX Announcement – 2017 Annual Report

The 2017 Dimerix Annual Report is now available here

ASX Announcement – WA Broker Meets Biotech presentation

Dimerix CEO Kathy Harrison is pleased to be speaking alongside a great collection of other biotech companies at the Western Australian [...]

ASX Announcement – Notice of security consolidation

Dimerix has announced a proposed consolidation of DXB shares. Full details of the notification are available here.